[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.155.6. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Article
June 1996

Factors Influencing Outcome of Surgery for Primary Aldosteronism

Author Affiliations

From the Sections of Surgical Oncology (Drs Celen and Beazley), Pathology (Dr O'Brien), and Endocrine Hypertension (Dr Melby), Boston University Medical Center Hospital, Mass.

Arch Surg. 1996;131(6):646-650. doi:10.1001/archsurg.1996.01430180072015
Abstract

Objective:  To identify factors that influence the outcome of surgery for primary aldosteronism.

Design:  A retrospective clinical series, with a mean follow-up of 106 months (range, 12-280 months), of 42 patients who underwent adrenalectomy for primary aldosteronism between the years 1970 and 1993.

Setting:  All patients were operated on at the Boston University Medical Center Hospital.

Patients and Intervention:  We reviewed the records of 22 women and 20 men, ranging in age from 25 to 68 years, who underwent adrenalectomy for primary aldosteronism. Tests performed for preoperative classification of the adrenal pathological abnormalities included adrenal venous sampling, postural stimulation test, iodocholesterol I 131 scintigraphy, and computed tomography.

Main Outcome Measures:  The surgical outcome was classified as follows: response, normal blood pressure measurement (<160/95 mm Hg) without medication; incomplete response, normal blood pressure measurement with medication or blood pressure measurement greater than 160/95 mm Hg despite antihypertensive treatment.

Results:  Twenty-five patients (60%) became normotensive following surgery. The following factors were associated with a complete response to adrenalectomy by univariate analysis: adenoma classification (odds ratio [OR]=9.6, P=.002); preoperative response to spironolactone (OR=8.3, P=.007); age younger than 44 years (OR=6.2, P=.009); and duration of hypertension less than 5 years (OR=5.1, P=.03). Response to spironolactone was predictive only in cases classified as adenoma (P=.004). Duration of hypertension showed a strong correlation with age (r=0.62). Using stepwise logistic regression, adenoma pathological classification, response to spironolactone, and duration of hypertension less than 5 years contributed independently to a predictive model. Micronodular hyperplasia alone was associated with incomplete response. The presence of coexisting micronodular hyperplasia in patients with adenoma did not affect the odds for a complete response. Computed tomography for preoperative diagnosis of adenoma showed the same level of accuracy (75%) as that for postural stimulation test and iodocholesterol scintigraphy, but less than that for adrenal venous sampling (91%).

Conclusions:  The study showed that the main determinants of a surgical cure of hypertension in primary aldosteronism were presence of adenoma and preoperative response to spironolactone. We favor computed tomography as the initial test to establish preoperative diagnosis of adenoma because of its reproducibility and high specifity.(Arch Surg. 1996;131:646-650)

References
1.
Conn JW.  Primary aldosteronism: a new clinical syndrome . J Lab Clin Med . 1955;45:6-17.
2.
Young WF Jr, Klee GG.  Primary aldosteronism: diagnostic evaluation . Endocrinol Metab Clin North Am . 1988;14:367-395.
3.
Melby JC.  Diagnosis and treatment of primary aldosteronism and isolated hypoaldosteronism . Clin Endocrinol Metab . 1985;14:977-995.Article
4.
Grant CS, Carpenter P, van Heerden JA, Hamberger B.  Primary aldosteronism: clinical management . Arch Surg . 1984;119:585-590.Article
5.
Horky K, Widimsky J Jr, Hradec E, Gregorova I, Hradec M.  Long-term results of surgical and conservative treatment of patients with primary hyperaldosteronism . Exp Clin Endocrinol . 1987;90:337-346.Article
6.
Obara T, Ito Y, Okamoto T, et al.  Risk factors associated with postoperative persistent hypertension in patients with primary aldosteronism . Surgery . 1992; 112:987-993.
7.
Milsom SR, Espiner EA, Nicholls MG, Gwynne J, Perry EG.  The blood pressure response to unilateral adrenalectomy in primary aldosteronism . QJM . 1986; 61:1141-1151.
8.
Lins PE, Adamson U.  Primary aldosteronism: a follow-up study of 28 cases of surgically treated aldosterone-producing adenomas . Acta Med Scand . 1987; 221:275-282.Article
9.
Weigel RJ, Wells SA, Gunnels JC, Leight GS.  Surgical treatment of primary hyperaldosteronism . Ann Surg . 1994;219:347-352.Article
10.
Groth H, Vetter M, Stimpel M, et al.  Adrenalectomy in primary aldosteronism: a long-term follow-up study . Cardiology . 1985;72:107-116.Article
11.
Auda SP, Brennan MF, Gill JR Jr.  Evolution of the surgical management of primary aldosteronism . Ann Surg . 1980;191:1-7.Article
12.
Ferris JB, Brown JJ, Fraser R, et al.  Results of adrenal surgery in patients with hypertension, aldosterone excess, and low plasma renin concentration . BMJ . 1975;1:135-138.Article
13.
Ferris JB, Beevers DG, Boddy K, et al.  The treatment of low-renin ('primary') hyperaldosteronism . Am Heart J . 1978;96:97-109.Article
14.
Conn JW, Knopf RF, Nesbit RM.  Clinical characteristics of primary aldosteronism from an analysis of 145 cases . Am J Surg . 1964;107:159-172.Article
15.
Hunt TK, Schambelan M, Biglieri EG.  Selection of patients and operative approach in primary aldosteronism . Ann Surg . 1975;182:353-361.Article
16.
Lim RC Jr, Nakayama DK, Biglieri EG, Schambelan M, Hunt TK.  Primary aldosteronism: changing concepts in diagnosis and management . Am J Surg . 1986;152:116-121.Article
17.
Ito Y, Fujimoto Y, Obara T.  Clinical significance of associated nodular lesions of the adrenal in patients with aldosteronoma . World J Surg . 1990;14:330-334.Article
18.
Favia G, Lumachi F, Scarpa V, D'Amico DF.  Adrenalectomy in primary aldosteronism: a long-term follow-up study in 52 patients . World J Surg . 1992;16: 680-684.Article
19.
Pratt JH, Holbrook MM, Dale SL, Melby JC.  The measurement of urinary tetrahydroaldosterone by radioimmunoassay . J Steroid Biochem . 1977;8:677-681.Article
20.
Antunes JR, Dale SL, Melby JC.  Simplified radioimmunoassay for aldosterone using antisera to aldosterone-γ-lactone . Steroids . 1976;28:621-630.Article
21.
Lins PE, Adamson U.  Plasma aldosterone-plasma renin activity ratio: a simple test to identify patients with primary aldosteronism . Acta Endocrinol Copenh . 1986;113:564-569.
22.
Herf SM, Teates DC, Tegtmeyer CJ, Vaughan ED Jr, Ayers CR, Carey RM.  Identification and differentiation of surgically correctable hypertension due to primary aldosteronism . Am J Med . 1979;67:397-402.Article
23.
Melby JC, Spark RF, Dale SL, Egdahl RH, Kahn PC.  Diagnosis and localization of aldosterone-producing adenomas by adrenal-vein catheterization . N Engl J Med . 1967;277:1050-1057.Article
24.
Doppman J.  The dilemma of bilateral adrenocortical nodularity in Conn's and Cushing's syndromes . Radiol Clin North Am . 1993;5:1039-1050.
25.
Spark RF, Melby JC.  Aldosteronism in hypertension: the spironolactone response test . Ann Intern Med . 1968;69:685-691.Article
26.
Brown JJ, Davies DL, Ferris JB, et al.  Comparison of surgery and prolonged spironolactone therapy in patients with hypertension, aldosterone excess, and low plasma renin . BMJ . 1972;2:729-734.Article
27.
Streeten DHP, Anderson GH, Wagner S.  Effect of age on response of secondary hypertension to specific treatment . Am J Hypertens . 1990;3:360-365.Article
×